Needham Maintains Staar Surgical(STAA.US) With Hold Rating
William Blair Maintains Staar Surgical(STAA.US) With Hold Rating
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $20
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Staar Surgical Analyst Ratings
Morgan Stanley Maintains Staar Surgical(STAA.US) With Sell Rating, Maintains Target Price $13
Wells Fargo Initiates Coverage On Staar Surgical With Equal-Weight Rating, Announces Price Target of $17
Staar Surgical Analyst Ratings
Staar Surgical Analyst Ratings
BTIG Keeps Their Hold Rating on Staar Surgical (STAA)
Needham Maintains Staar Surgical(STAA.US) With Hold Rating
CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Cuts Target Price to $17
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $20
A Quick Look at Today's Ratings for Staar Surgical(STAA.US), With a Forecast Between $17 to $17
Staar Surgical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), ACADIA Pharmaceuticals (ACAD) and Staar Surgical (STAA)
William Blair Maintains Staar Surgical(STAA.US) With Hold Rating
Staar Surgical (STAA) Was Downgraded to a Hold Rating at William Blair
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Staar Surgical Price Target Cut to $17.00/Share From $28.00 by Canaccord Genuity